Genomic Test for Breast Cancer Recurrence Found to be Cost-EffectiveSteven LewisHealthcarepapers
Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx study Breast cancerOncotype DXAdjuvant chemotherapyOlder patientsReal lifeThe 21-gene Oncotype DX Breast Recurrence Score test, (Genomic Health, Redwood City CA) ... S Barni,F Cognet...
METHOD: We interviewed 163 stage I or II breast cancer patients at a routine follow-up appointment. We assessed their health literacy (using the Rapid Estimate of Adult Learning in Medicine) as well as their knowledge of and attitudes towards a genomic test that identifies risk of recurrence ...
Oncotype DX has been extensively evaluated in multiple independent studies involving more than 2600 breast cancer patients, including rigorous validation studies. Genomic Healths goal is to build similar tests that can prove useful across a range of cancer types. 展开 关键词:...
The study authors examined 110 breast cancer survivors to explore associations between the genomic test’s recurrence score and its relationship to a range of factors: fear of cancer recurrence, distress, anxiety, depression, health-related quality of life, including pain ...
In the study, Gormley and her colleagues studied 110 breast cancer survivors to explore associations between the genomic test's recurrence score and its relationship to a range of factors: fear of cancer recurrence, distress, anxiety, depression, health-related quality of life, including pain and ...
Once you have decided on our breast cancer genomic testing - MammaPrint can be ordered alone or in combination with BluePrint.
Breast CancerHealth DisparitiesOncologyCancer GeneticsWomen's HealthHealth InequitiesGenetics and Genomics This Issue Views5,876 Citations14 47 Research Letter Diversity, Equity, and Inclusion March1,2022 Neha Goel, MD1;Daniel Y. Kim, BS2;Jimmy A. Guo, BA3;et alDaniel Zhao, BA4;Brandon A. Mah...
These attributes can describe health outcomes (e.g. test accuracy, likelihood or severity of treatment side effects) or intervention process (cost, test procedure, or turnaround time). In this study, we assumed that a genomically-guided cancer treatment could be described by seven attributes (...
Endometrial carcinoma remains a public health concern with a growing incidence, particularly in younger women. Preserving fertility is a crucial consideration in the management of early-onset endometrioid endometrial carcinoma (EEEC), particularly in patients under 40 who maintain both reproductive desire ...